EMG
EBS icon

Ellington Management Group’s Emergent Biosolutions EBS Stock Holding History

Ellington Management Group’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-6,600
Closed -$224K – 681
2017
Q2 		$224K Buy
+6,600
New +$204K 0.03% 498
2016
Q3 		– Sell
-7,700
Closed -$217K – 647
2016
Q2 		$217K Buy
7,700
+1,300
+20% +$51K 0.3% 123
2016
Q1 		$233K Buy
+6,400
New +$226K 0.1% 316
2015
Q1 		– Sell
-10,200
Closed -$278K – 710
2014
Q4 		$278K Buy
+10,200
New +$243K 0.09% 354

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return